• Boracay Hotels
• Cebu Hotels
• Free Articles Submissions

Bali Hotels

Web Related Articles

• Experimental Drug Shrinks Breast Tumors

An experimental drug can slash the number of chemotherapy-resistant cancer stem cells in women with advanced breast cancer, curbing tumor growth, researchers report....

• New Drug Shrinks Skin Cancer Tumors

An experimental drug appears to dramatically and rapidly shrink deadly skin cancer tumors, researchers report....

• Drug Combo Extends Life With Advanced Breast Cancer

For the first time, a drug treatment has been shown to extend the lives of women with metastatic breast cancer after Herceptin alone failed....

• Breast Cancer Treated by Freezing Tumors

In a small but promising study, researchers were able to kill breast cancer tumors by freezing them using a technique known as image-guided, multiprobe cryotherapy....

• Progress in Predicting Invasive Breast Cancer

Doctors are a step closer to being able to predict which women with noninvasive breast tumors will go on to develop invasive breast cancer -- and therefore whether or not they need more aggressive treatment....

• Breast Cancer Drug Fights Lung Cancer, Too

The anti-hormone drug tamoxifen, which is used to treat breast cancer, may also reduce the risk of dying from lung cancer, a study of over 6,000 women suggests....

• Breast Cancer Drug Eribulin Extends Survival

The new breast cancer drug eribulin (Halaven) extends survival two and a half months longer than other therapies for advanced breast cancer, researchers report....

• Drug Combo Wipes Out Tumor Cells

Giving a combination of the targeted drugs Herceptin and Tykerb before breast cancer surgery wipes out tumor cells in about twice as many women as either drug alone....

• Drug Combo Wipes Out Tumor Cells

Giving a combination of the targeted drugs Herceptin and Tykerb before breast cancer surgery wipes out tumor cells in about twice as many women as either drug alone....

• New Progress in Targeted Lung Cancer Therapy

New research offers hope that people with lung cancer will live longer if drug therapy is guided by the molecular traits of tumors....

• Bone Drug Fails in Breast Cancer Study

The bone-building drug Zometa does not appear to prevent breast cancer from coming back in most women, researchers report....

• Drug May Be New Option to Cut Breast Cancer Risk

Women over age 60 can safely take an estrogen-lowering drug to reduce their risk of getting breast cancer, a new study shows....

• Sea Sponge Drug May Fight Breast Cancer

A drug derived from sea sponges extended the lives of breast cancer patients whose cancer had come back -- despite as many as five rounds of chemotherapy -- by an average of two and a half months....

• Bone Drug May Prevent Return of Breast Cancer

A drug that battles bone loss may have added benefits for women with estrogen-sensitive breast cancers, significantly reducing the chance that their cancer will return or spread, a new study shows....

• Bone Drug May Prevent Return of Breast Cancer

A drug that battles bone loss may have added benefits for women with estrogen-sensitive breast cancers, significantly reducing the chance that their cancer will return or spread, a new study shows....

• Bone Drug May Prevent Return of Breast Cancer

A drug that battles bone loss may have added benefits for women with estrogen-sensitive breast cancers, significantly reducing the chance that their cancer will return or spread, a new study shows....

• Bone Drug May Extend Lives of Young Women With Breast Cancer

A drug given to protect bones during breast cancer treatment extended the lives of young women with the disease, researchers report....

• Tamoxifen, Evista Prevent Breast Cancer

Updated results from a large breast cancer prevention trial confirm that both the old standby tamoxifen and the osteoporosis drug Evista can substantially cut the risk of developing breast cancer in high-risk postmenopausal women....

• Tamoxifen: Risk of Rare Second Breast Cancer?

Breast cancer patients who take the drug tamoxifen for five or more years may be at increased risk of developing a rare but aggressive breast cancer in their opposite breast, but tamoxifen use shouldn't change, researchers report....

• Carriers of Breast Cancer Gene at Risk of Second Cancer

Women who have been successfully treated for cancer in one breast and who carry the BRCA1 or BRCA2 cancer gene are at increased risk for developing cancer in their other breast....

• Skin Cancer Drug Erivedge Approved

The FDA has approved Erivedge, a once-daily pill that can shrink disfiguring or metastatic basal cell carcinoma (BCC) tumors....

• Herceptin: Long-Term Benefits for Breast Cancer

High-risk breast cancer patients continue to derive benefits from the drug Herceptin even four years after stopping treatment, but questions remain about the biologic therapy’s safety when given with chemotherapy....

• Breast Cancer Deaths Drop Again

Breast cancer death rates continue to drop by 2% a year. Despite the decline, African-American women die of breast cancer 40% more often than white women....

• Less Toxic Treatment for Aggressive Breast Cancers?

A new study shows that a shorter, less toxic chemotherapy regimen that includes the drug Herceptin appears to be just as effective in women with HER-2 positive breast cancer as using a standard three-drug therapy with Herceptin, a strategy that can be harder on the heart....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....